SecBot SecBot
SC 13G ·Filed Nov 10, 2026

VERA

Vera Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6d 16h ago SEC0000093751-26-000740
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's passive 4.6% stake is a routine index-fund-level holding. Monitor for any future 13D conversion or material changes in position size, but no near-term activist pressure is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$30.03
T+0 close · Nov 10, 2026 · via day close
Latest settled
+1.50%
T+1 · $30.48
Vs SPY
+0.18%
α at T+1
Next horizon
T+5
in 5h
  1. T+0 · Nov 10 $30.03entry
  2. T+1 · 6d ago +1.50%α +0.18% · $30.48
  3. T+4 · todayOpen
  4. T+5 · in 5h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp disclosed a 4.6% passive stake in Vera Therapeutics as of September 30, 2026, via a new Schedule 13G. This follows a prior 13G filing by State Street in August 2026, indicating a slight reduction from the earlier filing. The filing confirms passive intent with no activist purpose.

Key Financial Metrics

Stake
4.6%
Stake Value
$101.2M
Investor
STATE STREET CORP
Investor Type
index fund

Key Facts

  • State Street Corp filed a Schedule 13G disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics common stock as of September 30, 2026.
  • The stake represents 4.6% of shares outstanding.
  • State Street certifies the shares were acquired and are held in the ordinary course of business, with no intent to change or influence control.
  • This is a new 13G filing by State Street; a prior 13G by State Street was filed on August 7, 2026.

Financial Impact

Passive stake of 4.6% valued at approximately $101 million based on the $2.2B market cap.

Risk Factors

  • No material risks identified from this passive filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000740
Document: 0000093751-26-000740-index.html0000093751-26-000740
Document: 0000093751-26-000740.txt0000093751-26-000740

Track record

25 reports on VERA

Performance horizon

13 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +36.47% at T+20 after the Jun 2, 2026 report. 14 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $27.55 Now $26.97 −2.11% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $28.15 Now $26.97 −4.19% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $28.15 Now $26.97 −4.19% settles Nov 23
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $30.03 Now $26.97 −10.19% settles Nov 17
  5. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  6. Nov 5, 202611d ago Press Release Bullish 6/10 Entry $29.79 to $28.10 Now $26.97 −9.45% ▼ −5.66% −8.25% vs SPY
  7. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $31.97 to $30.48 Now $26.97 −15.64% ▼ −4.66% −3.75% vs SPY
  8. Oct 22, 202625d ago Press Release Bullish 8/10 Entry $29.05 to $30.53 Now $26.97 −7.16% ▲ +5.09% +4.39% vs SPY
  9. Sep 15, 20268w ago 8-K Bullish 8/10 Entry $33.67 to $34.00 Now $26.97 −19.90% ▲ +0.98% +0.16% vs SPY
  10. Aug 10, 202614w ago 8-K Neutral 5/10 No price data
Showing 10 of 25

US Market Status

Market Closed · Opens in 7h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026